NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 5th
NEW YORK, Feb. 5, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 4th
NEW YORK, Feb. 4, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 3rd
NEW YORK, Feb. 3, 2025 /PRNewswire/ -- The New York Stock Exchange…
GH Research to Provide Update on Phase 2b Trial with GH001 in TRD
DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS),…
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR JANUARY 31st
NEW YORK, Jan. 31, 2025 /PRNewswire/ -- The New York Stock Exchange…
Ultimovacs ASA Reports Fourth Quarter 2024 Financial Results and Provides General Business Update
Oslo, January 31, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company…
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR JANUARY 30th
NEW YORK, Jan. 30, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR JANUARY 29th
NEW YORK, Jan. 29, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR JANUARY 28th
NEW YORK, Jan. 28, 2025 /PRNewswire/ -- The New York Stock Exchange…
FOXO TECHNOLOGIES, INC., PROVIDES UPDATE ON RECENT ACOMPLISHMENTS AND BUSINESS STRATEGY
MINNEAPOLIS, MN, Jan. 28, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the…